Lv41
502 积分 2023-09-06 加入
Discovery of Daclatasvir as a potential PD-L1 inhibitor from drug repurposing
8小时前
已完结
LW-213 induces immunogenic tumor cell death via ER stress mediated by lysosomal TRPML1
8小时前
已完结
Allosteric SHP2 inhibition enhances regorafenib's effectiveness in colorectal cancer treatment
9小时前
已完结
Targeting SHP2 reverses BRAF inhibitor tolerance in anaplastic thyroid carcinoma
1个月前
已关闭
ALKBH5 promotes the development of lung adenocarcinoma by regulating the polarization of M2 macrophages through CDCA4
1个月前
已完结
Preclinical development and clinical studies of targeted JAK/STAT combined Anti-PD-1/PD-L1 therapy
1个月前
已完结
Brusatol improves the efficacy of an anti-mouse-PD-1 antibody via inhibiting programmed cell death 1 ligand 1 expression in a murine head and neck squamous cell carcinoma model
1个月前
已完结
Immune escape of head and neck cancer mediated by the impaired MHC-I antigen presentation pathway
1个月前
已完结
Inhibitor Binding Sites in the Protein Tyrosine Phosphatase SHP-2
1个月前
已完结
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
2个月前
已完结
皖公网安备34019202002308
